| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | P | 30,000 | – | – |
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | P | 30,000 | – | – |
| Feb 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | P | 30,000 | – | – |
| Feb 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | P | 30,000 | – | – |
| Jan 29, 2025 | Stockwell Lynn | CEO and Executive COB | P | 400,000 | – | – |
| Jan 29, 2025 | Stockwell Lynn | CEO and Executive COB | S | 5,698,363 | – | – |
| Jan 29, 2025 | Stockwell Lynn | CEO and Executive COB | J | 400,000 | – | – |
| Jan 29, 2025 | Stockwell Lynn | CEO and Executive COB | P | 400,000 | – | – |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | P | 400,000 | – | – |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | S | 5,698,363 | – | – |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | J | 400,000 | – | – |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | P | 400,000 | – | – |
| Jan 29, 2025 | Worman Glenn C. | CFO | J | 100,000 | – | – |
| Jan 29, 2025 | Do Catherine | Director | J | 100,000 | – | – |
| Jan 29, 2025 | Prasad Sridhar G. | Director | J | 100,000 | – | – |
| Jan 29, 2025 | Shulgan Myron W. | Director | J | 100,000 | – | – |